Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Eledon Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −3 vs. Q3 2022
- Shares held
- 6.25M
- −17.1K (−0.3%) vs. Q3 2022
- Total value
- $14.4M
- −$2.92M (−16.9%) vs. Q3 2022
- New holders
- 2
- 7 more added
- Sold out
- 5
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 161 | $184.6M |
| Q1 2026 | 121 | $131.2M |
| Q4 2025 | 95 | $66.7M |
| Q3 2025 | 83 | $94.5M |
| Q2 2025 | 85 | $110.7M |
| Q1 2025 | 83 | $130.3M |
| Q4 2024 | 75 | $158.5M |
| Q3 2024 | 33 | $46.0M |
| Q2 2024 | 32 | $48.2M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 29 | $16.5M |
| Q3 2023 | 28 | $12.2M |
| Q2 2023 | 33 | $12.7M |
| Q1 2023 | 30 | $14.7M |
| Q4 2022 | 28 | $14.4M |
| Q3 2022 | 31 | $17.3M |
| Q2 2022 | 31 | $15.9M |
| Q1 2022 | 32 | $27.6M |
| Q4 2021 | 36 | $34.7M |
| Q3 2021 | 35 | $52.1M |
| Q2 2021 | 34 | $74.5M |
| Q1 2021 | 34 | $89.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1 | $2 | 0.00% | −1,132−99.9% | Reduced |
| Bank of America Corp | 14 | $32 | 0.00% | +14 | New |
| Wells Fargo & Company | 84 | $192 | 0.00% | +2+2.4% | Added |
| Rockefeller Capital Management L.P. | 1,666 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,898 | $4.00K | 0.00% | +1,258+196.6% | Added |
| UBS Group AG | 3,992 | $9.10K | 0.00% | +2,978+293.7% | Added |
| Mercer Global Advisors Inc | 16,726 | $38.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 17,954 | $42.0K | 0.00% | +40.0% | Added |
| Two Sigma Investments, LP | 21,637 | $49.3K | 0.00% | −8,100−27.2% | Reduced |
| Boothbay Fund Management, LLC | 22,050 | $50.3K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 25,600 | $58.4K | 0.00% | −16,600−39.3% | Reduced |
| Renaissance Technologies LLC | 29,673 | $68.0K | 0.00% | −2,200−6.9% | Reduced |
| Northern Trust Corp | 30,053 | $68.5K | 0.00% | 00.0% | Unchanged |
| SVB Financial Group | 40,613 | $93.1K | 0.25% | +40,613 | New |
| State Street Corp | 44,692 | $103.7K | 0.00% | 00.0% | Unchanged |
| Ingalls & Snyder LLC | 50,849 | $116.0K | 0.01% | −300−0.6% | Reduced |
| BlackRock Inc. | 51,770 | $118.0K | 0.00% | +2,405+4.9% | Added |
| Jmac Enterprises LLC | 54,538 | $124.3K | 0.03% | 00.0% | Unchanged |
| Eversept Partners, LP | 67,743 | $154.5K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 129,151 | $299.0K | 0.00% | −314−0.2% | Reduced |
| Ikarian Capital, LLC | 221,830 | $514.6K | 0.21% | 00.0% | Unchanged |
| CM Management, LLC | 234,800 | $535.0K | 0.64% | −10,200−4.2% | Reduced |
| Ensign Peak Advisors, Inc | 443,001 | $1.03M | 0.00% | +355,715+407.5% | Added |
| Woodline Partners LP | 516,675 | $1.18M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 679,557 | $1.55M | 0.00% | +3140.0% | Added |
| Cormorant Asset Management, LP | 1,217,882 | $2.78M | 0.19% | −5,618−0.5% | Reduced |
| BVF Inc | 2,326,710 | $5.40M | 0.23% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1 | – | – | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −375,000−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −339−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |